Company intelligence / Profile preview

Cape Fear BioCapital

Research Triangle Park / broader NC region, North Carolina, United Statescapefearbiocap.com ↗

Ownership: Private
Development stage: Other

Overview

Cape Fear BioCapital is a seed-stage venture capital fund dedicated to investing in early-stage therapeutics companies based in North Carolina. The firm focuses on catalyzing the formation and growth of biotech startups by providing initial funding for key development steps such as securing IP, building founding teams, and conducting proof-of-concept research. Their goal is to help launch at least 40 new biotech companies over the next decade.

Industry: Investors

Partnerships

Anchored by Moore Strategic Ventures as lead investorCo-investment model with other VCs for portfolio companies

Beyond the preview

Go deeper on Cape Fear BioCapital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cape Fear BioCapital.

Explore the full profile